Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GYRE THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 52K | Aug 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GYRE | GYRE THERAPEUTICS, INC. | Aug 14, 2024 | 1 | $0 | 4 | Aug 16, 2024 | Director |
GYRE | GYRE THERAPEUTICS, INC. | Mar 20, 2024 | 1 | $0 | 4 | Mar 21, 2024 | Director |
GYRE | GYRE THERAPEUTICS, INC. | Mar 20, 2024 | 0 | $0 | 3 | Mar 21, 2024 | Director |